.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
AstraZeneca
Harvard Business School
Accenture
Johnson and Johnson
Merck
Baxter
Novartis
Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

Felodipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for felodipine and what is the scope of felodipine patent protection?

Felodipine
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Glenmark Generics, Heritage Pharms Inc, Jubilant Generics, Mylan, Orchid Hlthcare, Sun Pharm Inds Ltd, Sun Pharm Industries, Torrent Pharms Ltd, Vintage Pharms Llc, Wockhardt Ltd, and Astrazeneca, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for felodipine. Twenty-two suppliers are listed for this compound.

Pharmacology for felodipine

Medical Subject Heading (MeSH) Categories for felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms IncFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL201964-002Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms IncFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL201964-003Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms IncFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL201964-001Nov 8, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL090365-003Dec 17, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant GenericsFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL203983-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL090365-002Dec 17, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms LtdFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL202170-003Nov 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL203417-002Jan 17, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt LtdFELODIPINEfelodipineTABLET, EXTENDED RELEASE;ORAL091484-002Aug 15, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-002Jul 25, 1991► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-001Jul 25, 1991► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-002Jul 25, 1991► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-001Jul 25, 1991► Subscribe► Subscribe
AstrazenecaPLENDILfelodipineTABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
US Army
Chubb
QuintilesIMS
Cipla
Boehringer Ingelheim
Medtronic
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot